Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team
WALTHAM, Mass.--(BUSINESS WIRE)--Apr 2, 2024--
Stay updated with breaking news from Vanqua Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WALTHAM, Mass.--(BUSINESS WIRE)--Apr 2, 2024--
Northwestern University professors Shana Kelley, Dr. Dimitri Krainc and Hooman Mohseni have been named 2023 fellows of the National Academy of Inventors (NAI).
CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- today announced that its development candidate VQ-101, a best-in-class brain-penetrant small molecule allosteric…
CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Vanqua Bio today announced that its development candidate VQ-101, a best-in-class brain-penetrant small molecule allosteric activator of glucocerebrosidase (GCase), will enter clinical development in the first quarter of 2024, with an initial indication in Parkinson’s disease (PD). To support the company’s clinical evolution, Vanqua Bio also announced the appointment of three executives to leadership roles: Jesse Cedarbaum, MD and Omer Siddiqui have
CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Vanqua Bio today announced that its development candidate VQ-101, a best-in-class brain-penetrant small molecule allosteric activator of glucocerebrosidase (GCase), will enter clinical development